Adjusted for race, stage, Gleason score, pre-radiotherapy PSA (continuous), hypertension, use of neoadjuvant therapy, and time from prostate cancer diagnosis to RT (continuous). The gene discussed is KLK3; the disease is hypertensive disorder.